Welcome to LookChem.com Sign In|Join Free
  • or
6-Bromo-1H-pyrrolo[3,2-b]pyridine is a heterocyclic compound characterized by the presence of a pyrrolo and pyridine ring fused together, with a bromine atom attached at the 6th position. This unique structure endows it with versatile chemical properties, making it a valuable intermediate in the synthesis of various pharmaceutical compounds.

944937-53-5

Post Buying Request

944937-53-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

944937-53-5 Usage

Uses

Used in Pharmaceutical Industry:
6-Bromo-1H-pyrrolo[3,2-b]pyridine is used as a key intermediate in the synthesis of benzofuran and pyridine compounds for the treatment of viral diseases, respiratory illnesses, and inflammatory diseases. Its unique structure allows for the development of novel therapeutic agents with potential antiviral, anti-inflammatory, and respiratory benefits.
In the preparation of benzofuran compounds, 6-Bromo-1H-pyrrolo[3,2-b]pyridine serves as a building block, enabling the creation of new molecules with potential antiviral properties. These benzofuran-based compounds can target specific viral enzymes or pathways, offering a new approach to treating viral infections.
For the development of pyridine compounds, 6-Bromo-1H-pyrrolo[3,2-b]pyridine acts as a crucial component in the synthesis process. These pyridine-based compounds can exhibit anti-inflammatory and respiratory benefits, providing new treatment options for patients suffering from inflammatory and respiratory conditions.
Overall, 6-Bromo-1H-pyrrolo[3,2-b]pyridine plays a significant role in the pharmaceutical industry, contributing to the advancement of new therapeutic agents for a range of diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 944937-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,9,3 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 944937-53:
(8*9)+(7*4)+(6*4)+(5*9)+(4*3)+(3*7)+(2*5)+(1*3)=215
215 % 10 = 5
So 944937-53-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5BrN2/c8-5-3-7-6(10-4-5)1-2-9-7/h1-4,9H

944937-53-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (ADE000947)  6-Bromo-1H-pyrrolo[3,2-b]pyridine  AldrichCPR

  • 944937-53-5

  • ADE000947-1G

  • 7,411.95CNY

  • Detail

944937-53-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Bromo-1H-Pyrrolo[3,2-B]Pyridine

1.2 Other means of identification

Product number -
Other names 6-bromo-1H-pyrrolo[3,2-b]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:944937-53-5 SDS

944937-53-5Relevant academic research and scientific papers

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

-

, (2013/03/26)

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

-

, (2013/03/26)

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 944937-53-5